Rossari Biotech Ltd · NSE:ROSSARI

Rossari Biotech — Q4 FY2021 Earnings Presentation

18 slides from Rossari Biotech's earnings presentation, May 15, 2021

  1. Slide 1: Exchange filing cover letter: Q4 & FY21 Earnings Presentation

    ROSSARI making you more competitive May 15, 2021 DCS-CRD Listing Compliance BSE Limited National Stock Exchange of India Ltd. First Floor, New Trade Wing Exchange Plaza, 5th Floor Rotunda Building, Phiroze Jeejeebhoy Towers Plot No.C/1, 'G'Block, Bandra- Kurla Complex Dalal Street, Fort Mumbai 400 0

  2. Slide 2: Rossari Biotech Limited Q4 & FY21 Results Presentation

    ® ROSSARI maki rig you mor,e comp,etitive Rossari Biotech Limited Q4 & FY21 Results Presentation May 14, 2021

  3. Slide 3: Disclaimer

    ® Disclaimer ROSSARI making you more competitive Certain statements and opinions with respect to the anticipated future performance of Rossari Biotech Ltd (Rossari) in the presentation (“forward-looking statements”), which reflect various assumptions concerning the strategies, objectives and anticip

  4. Slide 4: Q4 & FY21 Results Overview

    " ROSSARI making you more competitive Q4 & FY21 Results Overview 3

  5. Slide 5: Q4 FY21 – Key Financial Highlights

    ® Q4 FY21 – Key Financial Highlights ROSSARI making you more competitive Revenue from Operations EBITDA PAT (Rs. crore) (Rs. crore) (Rs. crore) 21.6 22.2 218.2 34.0 35.2 210.0 15.1 159.5 24.0 Q4 FY20 Q3 FY21 Q4 FY21 Q4 FY20 Q3 FY21 Q4 FY21 Q4 FY20 Q3 FY21 Q4 FY21 Shift % (Y-o-Y) 36.8% Shift % (Y-o-Y

  6. Slide 6: FY21 – Key Financial Highlights

    ® FY21 – Key Financial Highlights ROSSARI making you more competitive Revenue from Operations EBITDA PAT (Rs. crore) (Rs. crore) (Rs. crore) 80.0* 709.3 123.0 65.2 600.1 104.8 FY20 FY21 FY20 FY21 FY20 FY21 Shift % (Y-o-Y) 18.2% Shift % (Y-o-Y) 17.4% Shift % (Y-o-Y) 22.7% EBITDA PAT 17.5% 17.4% 10.9%

  7. Slide 7: Management Message

    " Management Message ROSSARI making you more competitive Commenting on the performance, in a joint statement, Mr. Edward Menezes, Promoter & Executive Chairman, and Mr. Sunil Chari, Promoter & Managing Director, said “We are pleased to share that we have reported a strong operational and financial p

  8. Slide 8: Key Developments

    ® Key Developments ROSSARI making you more competitive All phases of Rossari’s Greenfield manufacturing facility at Dahej, Gujarat fully operationalized  During the quarter, the Company successfully commissioned all phases of its Greenfield manufacturing facility at Dahej, Gujarat  The facility is

  9. Slide 9: Key Developments

    ® Key Developments ROSSARI making you more competitive Announces annual dividend of Rs. 0.50 per share  For FY 2020-21, the Board of Directors recommended a dividend of Rs. 0.50 /- per share  For details on dividend distribution policy, please refer to the Company’s website at Rossari - Dividend D

  10. Slide 10: Abridged P&L Statement - Consolidated

    ® Abridged P&L Statement - Consolidated ROSSARI making you more competitive Y-o-Y Change Y-o-Y Change Particulars (Rs. crore) Q4 FY21 Q4 FY20 FY21 FY20 (%) (%) Revenues from Operations 218.2 159.5 36.8% 709.3 600.1 18.2% Total Expenditure • Raw Material expenses 150.6 98.8 52.4% 462.2 371.7 24.3% •

  11. Slide 11: Consolidated Balance Sheet

    ® Consolidated Balance Sheet ROSSARI making you more competitive EQUITY AND LIABILITIES CONSOLIDATED CONSOLIDATED ASSETS CONSOLIDATED CONSOLIDATED As on 31st March 2021 As at 31st March 2020 As on 31st March 2021 As at 31st March 2020 Particulars (Rs. crore) Particulars (Rs. crore) (Audited) (Audite

  12. Slide 12: Consolidated Cash Flows

    ® Consolidated Cash Flows ROSSARI making you more competitive CASH FLOW CONSOLIDATED CONSOLIDATED CASH FLOW CONSOLIDATED CONSOLIDATED As on 31st March 2021 As at 31st March 2020 As on 31st March 2021 As at 31st March 2020 Particulars (Rs. crore) Particulars (Rs. crore) (Audited) (Audited) (Audited)

  13. Slide 13: Q4 FY21 - Segment-wise Details

    ® Q4 FY21 - Segment-wise Details ROSSARI making you more competitive Segment-wise Revenue Break-up (Rs. crore) ■ Q4 FY20 ■ Q3 FY21 ■ Q4 FY21 119.6 108.5 87.9 76.6 78.2 67.4 15.5 21.8 12.2 HPPC TSC AHN Shift (Y-o-Y) % 41.6% 30.4% 40.6% Shift (Q-o-Q) % -9.3% 12.4% 78.7% Key Highlights:  Growth driven

  14. Slide 14: Q4 & FY21 - Financial and Operational Discussions (Y-o-Y)

    ® Q4 & FY21 - Financial and Operational Discussions (Y-o-Y) ROSSARI making you more competitive Net Revenues Q4 FY21 Revenues from operations stood at Rs. 218.2 crore, higher by 36.8% YoY; FY21 Revenues from operations up 18.2% YoY to Rs. 709.3 crore  HPPC business continued to report strong volume

  15. Slide 15: Annexure

    ROSSARI making you more competitive Annexure 14

  16. Slide 16: Conference Call Details

    ® Conference Call Details ROSSARI making you more competitive Q4 & FY21 Earnings Conference Call Time • 04:00 p.m. IST on Monday, May 17, 2021 To enable participants to connect to the conference call without Pre-registration having to wait for an operator, please register at the below mentioned link

  17. Slide 17: About Us

    ® About Us ROSSARI making you more competitive Rossari Biotech Limited (Rossari) (BSE: 543213, NSE: ROSSARI), is a For further information, please contact: Speciality-Chemicals manufacturer providing intelligent and sustainable solutions for customers across industries. Headquartered at Mumbai, Indi

  18. Slide 18: Thank you

    ® ROSSARI making you more competitive Thanky•u 17

Rossari Biotech — Q4 FY2021 Earnings Presentation on 6ix